Pancreatic Neoplasms: all 3,310 studies
Page 1 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.
- Becotatug Vedotin Plus Anti-PD-1 and S-1 in Patients With EGFR-Positive Advanced Pancreatic Cancer Who Have Failed at Least One Line of Standard TherapyRecruitingNCT07892573Not applicable
- Phase 1 Study of NW-301V TCR-T Cells in Advanced Solid Tumors With KRAS G12V MutationNot yet recruitingNCT07875920Phase 1
- Diagnostic Utility of Protein Biomarkers in Pancreatic Ductal AdenocarcinomaRecruitingNCT07875582
- Histotripsy x Pancreatic CancerRecruitingNCT07873606Not applicable
- Utilizing Standard of Care Induction Chemotherapy Followed by MR-LINAC Radiotherapy and Surgical Exploration to Improve Resectability Rates in Potentially Resectable Locally Advanced Pancreatic CancerNot yet recruitingNCT07871461Phase 2
- Trial of First-line Gemcitabine and Nab-paclitaxel With or Without L-glutamine in Advanced Pancreatic CancerNot yet recruitingNCT07864571Phase 2
- Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal AdenocarcinomaRecruitingNCT07845617
- Studies of Blood Glucose and the Microbiome in Tumors and Cysts of the PancreasNot yet recruitingNCT07843147
- A Prospective Study of Concurrent Hyperthermia, Chemotherapy and Radiotherapy in Borderline and Locally Advanced Pancreatic Cancer (PANHEAT)Not yet recruitingNCT07839676Not applicable
- Surufatinib in Combination With Iparomlimab and Tuvonralimab Injection and AG Chemotherapy for Neoadjuvant Therapy of HRPC or BRPCNot yet recruitingNCT07833241Phase 2
- Albumin-bound Paclitaxel (Ⅱ)-Combined Regimens for Pancreatic CancerNot yet recruitingNCT07828756Phase 2
- PHASE 1 TRIAL OF Lm-LLO-TT AND GEMCITABINE IN UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMANot yet recruitingNCT07828236Phase 1
- Predicting Pancreatic Fistula After Pancreatic Surgery Using Preoperative ImmunityNot yet recruitingNCT07827911
- The STRONG Nutrition Support Study for People With Pancreatic CancerNot yet recruitingNCT07826780Not applicable
- Outcomes of Fluoroscopy-Guided Transdiscal Splanchnic Nerve Neurolysis for Upper Abdominal Cancer Pain.Not yet recruitingNCT07825870Not applicable
- Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast CancerNot yet recruitingNCT07825753Phase 2
- Neoadjuvant Avutometinib/Defactinib and mFOLFIRINOX Combination Therapy in Pancreatic AdenocarcinomaNot yet recruitingNCT07824960Phase 1/2
- A Study Evaluating a New Radiation Treatment Workflow (NGDS)RecruitingNCT07824583Not applicable
- Study of XNW28012 in Subjects With Metastatic Pancreatic Cancer Who Received Prior Systemic TherapyRecruitingNCT07823049Phase 3
- A Study of MGC030 in Participants With Advanced Solid TumorsNot yet recruitingNCT07822399Phase 1
- Personalised Nutritional Care in Older Patients With Pancreatic Ductal AdenocarcinomaNot yet recruitingNCT07821554Not applicable
- Real-world Evaluation of Different Endoscopic Biliary Drainage Techniques in Patients With Jaundice of Biliopancreatic Malignant OriginNot yet recruitingNCT07817602
- CREO - Microwave Ablation Feasibility StudyRecruitingNCT07817147Not applicable
- A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial EnrollmentNot yet recruitingNCT07814872
- Retlirafusp Alfa Combined With Famitinib, Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic CancerNot yet recruitingNCT07814859Phase 2
- Feasibility of the Loop Brush EUS-FNA for Characterization of Pancreatic Cysts: Pilot Clinical InvestigationNot yet recruitingNCT07814326Not applicable
- A Multicenter, Open-label, Phase II Umbrella Study to Evaluate the Efficacy and Safety of the Investigational Product in Participants With Advanced or Metastatic Pancreatic CancerNot yet recruitingNCT07814066Phase 2
- Real-Time AI During Pancreatoscopy for Detection of Pancreatic NeoplasiaNot yet recruitingNCT07809841
- A Decision Support Tool for Pancreatic Cancer Screening -Aim 2Not yet recruitingNCT07808671Not applicable
- ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese CohortRecruitingNCT07808164
- An Open-Label, Multicenter, Phase IB/II Clinical Study of HRS-7172 in Combination With Antitumor Therapy in Participants With Solid TumorsNot yet recruitingNCT07806058Phase 1/2
- Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic AdenocarcinomaRecruitingNCT07805954Phase 3
- Observational Registry Evaluating the Clinical Impact of the Blood-Based Biomarker Test for Early-Stage Pancreatic Ductal AdenocarcinomaNot yet recruitingNCT07805681
- A Study to Compare the Efficacy and Safety of YL201 With Standard Chemotherapy in Patients With Metastatic Pancreatic Cancer After Failure of Gemcitabine-Based Systemic ChemotherapyNot yet recruitingNCT07803783Phase 3
- EUS-Based Artificial Intelligence to Predict Outcomes in Pancreatic CancerNot yet recruitingNCT07803770
- Molecularly Tailored Therapy in Advanced Pancreatic CancerNot yet recruitingNCT07802418Phase 2
- GnP Combined With SHR-1701 and Apatinib as First-Line Treatment for Locally Advanced or Metastatic PDACNot yet recruitingNCT07802184Phase 1/2
- Spleen Preservation Versus Splenectomy in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)Not yet recruitingNCT07799298Not applicable
- GI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial PancreatectomyNot yet recruitingNCT07796997Phase 1
- Five-Element Music Therapy for Psychological Distress in Pancreatic Cancer ChemotherapyNot yet recruitingNCT07796906Not applicable
- Pancreatic Cancer Lifestyle Evolution And ResistanceNot yet recruitingNCT07794969
- Baduanjin for Quality of Life in Pancreatic Cancer ChemotherapyNot yet recruitingNCT07791550Not applicable
- Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility TrialRecruitingNCT07787156Not applicable
- A Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 in Patients With Previously Treated Locally Advanced Unresectable or Metastatic Pancreatic Cancer Harboring KRAS G12D MutationRecruitingNCT07784374Phase 2
- Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With CancerNot yet recruitingNCT07781852Early Phase 1
- Understanding New Cachexia Subtypes Through Observational Epidemiological ResearchRecruitingNCT07776353
- Retlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic CancerNot yet recruitingNCT07773363Phase 2
- Wearable-Supported Prehabilitation and Rehabilitation for Patients Undergoing Surgery for Pancreatic CancerNot yet recruitingNCT07772258Not applicable
- Vilastobart+Retifanlimab in BRCA or PALB2 Deficient PCNot yet recruitingNCT07765836Phase 2
- EUS-DFI in Solid Pancreatic LesionsNot yet recruitingNCT07763561
- YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic MalignanciesRecruitingNCT07763301Phase 1
- Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic PancreatitisNot yet recruitingNCT07762950
- 68Ga-SorB PET/CT Imaging in Patients With Solid TumorsRecruitingNCT07760012Not applicable
- First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic CancerNot yet recruitingNCT07756281Phase 1
- A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C MutationNot yet recruitingNCT07752875Phase 1/2
- Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic CancerNot yet recruitingNCT07745790Phase 2
- Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic LesionsRecruitingNCT07737171
- A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic CancerNot yet recruitingNCT07736612Phase 1/2
- Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)RecruitingNCT07733674Phase 1
- Evaluating the Effectiveness of AIT in the Treatment of Pain Related to Pancreatic CancerNot yet recruitingNCT07733427Not applicable
- Analysis of Breath Volatile Organic Compounds Using Mass SpectrometryNot yet recruitingNCT07732686
- Structured Case-Finding for Pancreatic Ductal Adenocarcinoma in Swiss Primary Care: A Feasibility StudyNot yet recruitingNCT07723781
- Breath Research Narrow Validation for Gastrointestinal Cancer DetectionRecruitingNCT07714538
- Study on the Construction and Application of a Large Model Corpus for Pancreatic Cancer Based on Real Clinical CasesNot yet recruitingNCT07713823
- Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic CancerNot yet recruitingNCT07707674Phase 1
- A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic CancerRecruitingNCT07707531Early Phase 1
- Energy Expenditure and Nutrition After Pancreatic SurgeryRecruitingNCT07703813
- A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Pancreatic CancerRecruitingNCT07701486Phase 1/2
- A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease MonitoringRecruitingNCT07700992
- Frequency of Care for Peripherally Inserted Central Vascular Access In the Prevention of MarsiEnrolling by invitationNCT07697170Not applicable
- Neoadjuvant HRS-4642 Plus Chemotherapy With or Without Immunotherapy for Pancreatic CancerNot yet recruitingNCT07691593Phase 2
- A Phase-II Clinical Trial of Radiotherapy to the Coeliac Plexus to Help Pain in Advanced Pancreatic CancerNot yet recruitingNCT07689955Phase 2
- Trial of DN022150 Versus Chemotherapy in Previously Treated Advanced Pancreatic Cancer With KRAS G12D MutationNot yet recruitingNCT07689539Phase 3
- SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic CancerRecruitingNCT07683221Phase 2
- INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE StudyRecruitingNCT07671937Not applicable
- A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic CancerRecruitingNCT07671339Phase 1
- Exocrine-Endocrine Pancreatic Crosstalk: Precision Pathways to Reframe Diabetes PathophysiologyNot yet recruitingNCT07670871
- Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer CachexiaRecruitingNCT07670286
- Study of Occupational Risk Factors for Biliary and Pancreatic CancersNot yet recruitingNCT07668024
- Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic CancerNot yet recruitingNCT07665684Phase 1/2
- Determining Minimal Residual Disease Using ctDNA Deep SequencingRecruitingNCT07660627Not applicable
- Digitally Supported Prehabilitation Before Major Visceral Cancer SurgeryNot yet recruitingNCT07658313Not applicable
- Indocyanine Green-Guided Versus Standard Laparoscopic Distal Pancreatectomy for Pancreatic Body and Tail LesionsRecruitingNCT07656571Not applicable
- Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12D MutationNot yet recruitingNCT07656376Phase 2/3
- TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE)Not yet recruitingNCT07653594Not applicable
- A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant ChemotherapyRecruitingNCT07651358Not applicable
- A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)Not yet recruitingNCT07650357Phase 1
- A Study of Dose Escalation of ES502 in Patients With Advanced Pancreatic CancerRecruitingNCT07649928Early Phase 1
- A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerRecruitingNCT07644559Phase 2
- Evaluation of [⁶⁸Ga/¹⁷⁷Lu]HT547: Safety, Biodistribution, and Dosimetry in Solid TumorsNot yet recruitingNCT07639970Early Phase 1
- Prehabilitation in High-risk Oncologic SurgeryRecruitingNCT07638410Not applicable
- Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac PainRecruitingNCT07636382Not applicable
- Radiotherapy With GX Regimen as Adjuvant Therapy for High-risk Patients Following Pancreatic Cancer SurgeryRecruitingNCT07632118Phase 3
- Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid TumorNot yet recruitingNCT07631884Phase 2
- An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard TherapyNot yet recruitingNCT07631871Phase 2
- A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS MutationsRecruitingNCT07629960Phase 1/2
- BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in CancerRecruitingNCT07629609Phase 2
- Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal AdenocarcinomaRecruitingNCT07627711Phase 1/2
- GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular CancerRecruitingNCT07627191Early Phase 1
- Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )RecruitingNCT07621718Phase 3